Drugs Made In America Acquisition II Stock
Drugs Made In America Acquisition II Corp. Ordinary Shares
Company data
- Sector
- Financial Services
- Industry
- Financial - Conglomerates
- Country
- United States
- CEO
- Roger Bendelac
- Employees
- 2
- Market cap
- $648 M
- IPO
- 04/12/2025
- Web
- dmaacorp.com
Drugs Made In America Acquisition II Corp. currently lacks significant business operations. Its core objective is to execute a business combination, which may take various forms such as a merger, an acquisition of assets or shares, a recapitalization, or a reorganization, with one or more other entities. The company…
Drugs Made In America Acquisition II stock: price history
1D
-0.1%
1W
-0.1%
1M
+0.2%
6M
+1.7%
YTD
+2.8%
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Drugs Made In America Acquisition II
Drugs Made In America Acquisition II stock metrics
P/E
0.39
P/B
0.01
EV/EBITDA
-4.01
RETURN ON EQUITY
0.9%
NET MARGIN
0.0%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
77.9%
FLOAT SHARES
49,591,660
AVG. DAILY VOLUME (30D)
151,116
Institutional holders
Comparable stocks
Frequently asked questions about Drugs Made In America Acquisition II stock
What does Drugs Made In America Acquisition II do?
Drugs Made In America Acquisition II Corp. Ordinary Shares is a company in the Financial Services sector, Financial - Conglomerates industry, headquartered in United States.
The CEO is Roger Bendelac, the company employs around 2 people.
The IPO was on 04/12/2025; the stock trades on NASDAQ under the ticker DMII.
Does Drugs Made In America Acquisition II pay a dividend?
No, Drugs Made In America Acquisition II currently does not pay a dividend.
Which stocks are comparable to Drugs Made In America Acquisition II?
Comparable stocks include Freedom Holding, Art Technology Acquisition, Berkshire Hathaway, Berkshire Hathaway, JPMorgan Chase &, Visa, Mastercard and Morgan Stanley.
How can I get Drugs Made In America Acquisition II stock analyzed?
Clicking "Analyze stock" lets five strategies assess Drugs Made In America Acquisition II against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.